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Abstract Agents including the effect on sodium channel
are restricted in patients with Brugada electrocardiogram
(ECG) pattern or Brugada syndrome. On the other hand,
many therapeutic agents for cluster headache (CH) block
sodium channel. After recommended therapies without
sodium channel blocking effect were failed in a 40-year-
old male with CH whose ECG shows Brugada ECG pat-
tern, clonazepam and codein phosphate, which are
exceptional treatments for CH, were effective for severe
unilateral orbital pain.
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Introduction
Cluster headache (CH) is one of the syndromes of tri-
geminal autonomic cephalalgias, which is characterized by
severe unilateral pain localized to orbital, temporal, and
midface areas accompanied by typical autonomic symp-
toms [1]. On the other hand, Brugada syndrome is known
for a cause of sudden death due to ventricular fibrillation,
and is characterized by ST-segment elevation in the
precordial electrocardiogram (ECG) leads (V1–3) associ-
ated with right bundle branch block [2, 3]. The same ECG
pattern in patients without clinical symptoms (e.g., syn-
cope, cardiac arrest, family history, etc.) is diagnosed as
Brugada ECG pattern [4, 5]. Prevalence of CH is estimated
to be 0.1–0.4% [1] and that of Brugada ECG pattern is
0.1% [5]. Therefore, a case of CH with Brugada ECG
pattern is likely very rare.
Agents including the effect of sodium channel block are
restricted in patients with Brugada ECG pattern or Brugada
syndrome, as these have the potential to induce sudden
cardiac arrest. Many treatments for CH, however, include
sodium channel blocking effect, such as local anesthetics,
lithium, and verapamil [1, 6]. Therefore, it would be dif-
ficult to treat severe headache in a case for CH patient
accompanied with either Brugada syndrome or Brugada
ECG pattern, especially if therapies without the effect on
sodium channel were failed.
Case report
A 40-year-old Japanese male, who was diagnosed with
Brugada ECG pattern (Fig. 1), was complained of CH. He
had no history of ventricular tachycardia/fibrillation and
familial sudden cardiac death.
The characteristics of pain was a severe right orbital
pain occurring spontaneously at least one time in a day,
lasting for 3 months in a year. This headache associated
with tearing eyes and rhinorrhea. Alcohol intake aggra-
vated the attacks of pain. Sumatriptan or oxygen inhalation
had been used for symptomatic treatment, and prednisolone
and valproic acid had been used as preventive treatment for
over 10 years in Fukui Prefectural Hospital. Severity of
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headache, however, has been aggravated gradually in spite
of these treatments, and he was inquired for further treat-
ment in Pain Clinic in University of Fukui, Faculty of
Medical Sciences.
Although we prescribed zolmitriptan (2.5 mg p.o.) for
attack and lomerizine (10–20 mg/day p.o.) for prevention
at first, severity of headache and the number of attacks
showed no change after prescription for 2 weeks. Local
anesthestics for nasal instillation and nerve blocks, and also
verapamil were not selected, because these agents block
sodium channel and can induce lethal arrhythmias in a
patient with Brugada syndrome or Brugada ECG pattern
[7–11]. Then, we selected clonazepam and codein phos-
phate, which are exceptional treatments for CH [6, 12–14].
Clonazepam (2 mg/day p.o.) and codein phosphate
(120 mg/day p.o.) suppressed severity of headache dra-
matically without ECG change. Frequency of attacks,
however, showed no change.
Discussion
The ECG patterns in Brugada syndrome are divided into
two types in association with a shape of ST-segment ele-
vation; coved- and saddle-back type. Sodium channel gene
mutations are associated with Brugada syndrome, and
therapeutic use of agents including sodium channel
blocking effect is prohibited as it can induce ventricular
fibrillation [2, 3]. Individuals with Brugada ECG pattern
also have a risk of sudden death [4]. Local anesthetics
block sodium channel. Epidural anesthesia with bupiva-
caine unmasked a subclinical form of Brugada ECG pattern
or Brugada syndrome [7, 8]. Thoracic paravertebral block
with ropivacaine induced ventricular tachycardia in a
patient with Brugada syndrome [9]. Verapamil, a calcium
blocker, also blocks sodium channel. Verapamil, used in
patient with Brugada syndrome, caused ventricular fibril-
lation [10, 11].
Treatments for CH is divided into acute therapy aimed
at aborting individual attacks and prophylactic therapy
aimed at preventing recurrent attacks [1, 6]. Acute therapy
includes inhalation of 100% oxygen, nasal instillation of
lidocain, subcutaneous sumatriptan, and ergot derivatives.
As preventive therapy, there are verapamil, lithium, corti-
costeroids, and nonsurgical and surgical procedures (e.g.,
greater occipital nerve block, neurostimulation of the
occipital nerve) [1, 6]. Among these recommended thera-
peutics, nasal instillation of lidocaine, nerve block with
local anesthetics, and verapamil cannot be used in patients
of CH accompanying with Brugada syndrome.
Clinical management with regard to the treatment for
sudden cardiac death of asymptomatic patients with
Brugada ECG pattern has yet to be determined [5]. Not all
patients with Brugada ECG pattern are affected by Brugada
syndrome. Mediastinal tumor is reported to cause Brugada
ECG pattern [15]. Therefore, if careful examination elim-
inated a risk of sudden cardiac death in patients with both
CH and Brugada ECG pattern, therapeutic agents for CH
including sodium channel blocking effect could be used in
these patients.
We treated a patient suffering from CH associated
with Brugada ECG pattern, after the recommended
therapeutics without the effect of sodium channel block
were failed. As a risk of sudden cardiac death was not
completely eliminated in this patient, we decided not to
use agents including sodium channel blocking effect.
Prescription of clonazepam and codein phosphate
decreased the intensity of headache, although frequency
of the attack showed no change. Both opioids and anti-
convulsants without sodium channel blocking effects,
such as clonazepam, gabapentin, and baclofen might be a
therapeutic choice for CH accompanied with Brugada
syndrome or Brugada electrocardiogram pattern. Surgical
procedures, such as neurostimulation of the occipital
nerve, might also be substituted for the treatment in this
patient.
Fig. 1 Saddle-back type ST-segment elevation in lead V2
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